Clinical Biochemical Genetics · Austin, TX
NPI
1023121159
Since 2006
Specialty
Clinical Biochemical Genetics
Code 207SG0202X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1301 Barbara Jordan Blvd Ste 200
Austin, TX, 78723
Phone (512) 628-1840
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$2.2M
92 prescriptions
Company payments, 2025
$155
From 3 companies
Medicare prescription drug claims, 2024
In 2024, the drug James Gibson prescribed most often to Medicare patients was Vpriv (Velaglucerase Alfa), with 25 prescriptions and refills. In total James Gibson wrote 92 Medicare prescriptions that cost $2.2M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-01-10.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Vpriv Velaglucerase Alfa | 25 | 25 | Under 11 | $635K |
| Chenodal Chenodiol | 12 | 12 | Under 11 | $555K |
| Gabapentin Generic | 11 | 11 | Under 11 | $76.05 |
Brand drugs: 42 claims; generic drugs: 50 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James Gibson $155 ($155 in general payments such as food, travel and fees) from 3 companies. The largest payer was Zevra Therapeutics Inc with $132.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.